Cymbalta (Duloxetine Hydrochloride) is a new antidepressant. What is
interesting is that it is SNRI (serotonin and noradrenaline uptake inhibitor)
of which only Effexor was the only FDA approved drug of that class
until now. If you go to Cymbalta
site you only read that its only for depression. What they are not
saying is that the SNRIs are excellent for treating depression with
anxiety. But they probably haven't done the studies yet for approval
from the FDA.
At this time very few effectiveness studies are available.
Lessened side effects for this class of drug (SNRI & SSRI)
reported. No weight gain. Antidepressant effects should be reached
after one week. Physicians
Handout.
During initial case study one successful suicide reported.
Another SNRI Milnacipran is being used in France. Its being
marketed for Fibromyalgia since it appears to have some analgesic
affects. It is now in Phase 2 studies.
